Skip to main content

ADVERTISEMENT

E. Murat Tuzcu, MD

Original Contribution
10/01/2012
Abstract: Background. The clinical benefit of percutaneous interventional therapies for atherosclerotic renal artery stenosis (ARAS) is still obscure. Randomized trials conducted on general patient populations provided unsatisfactory results...
Abstract: Background. The clinical benefit of percutaneous interventional therapies for atherosclerotic renal artery stenosis (ARAS) is still obscure. Randomized trials conducted on general patient populations provided unsatisfactory results...
Abstract: Background. The...
10/01/2012
Journal of Invasive Cardiology
Rapid Communication
10/31/2012
Abstract: Background. The role of percutaneous closure of patent foramen ovale (PFO) in patients with cryptogenic stroke or transient ischemic attack remains controversial. Registry data have suggested considerable benefit of closure over...
Abstract: Background. The role of percutaneous closure of patent foramen ovale (PFO) in patients with cryptogenic stroke or transient ischemic attack remains controversial. Registry data have suggested considerable benefit of closure over...
Abstract: Background. The role...
10/31/2012
Journal of Invasive Cardiology
10/19/2012
Abstract: Background. The role of percutaneous closure of patent foramen ovale (PFO) in patients with cryptogenic stroke or transient ischemic attack remains controversial. Registry data have suggested considerable benefit of closure over...
Abstract: Background. The role of percutaneous closure of patent foramen ovale (PFO) in patients with cryptogenic stroke or transient ischemic attack remains controversial. Registry data have suggested considerable benefit of closure over...
Abstract: Background. The role...
10/19/2012
Journal of Invasive Cardiology